Homologous recombination repair mutation gene panels (excluding BRCA) are not predictive of maintenance olaparib plus bevacizumab efficacy in the first-line PAOLA-1/ENGOT-ov25 tria... by Pujade-Lauraine, Eric, MD, PhD, Brown, Jessica, MD PhD, Barnicle, Alan, Rowe, Phil, MSc, Lao-Sirieix, Pierre, PhD, Criscione, Steven, du Bois, Andreas, MD, PhD, Lorusso, Domenica, MD, Romero, Ignacio, MD, Petru, Edgar, MD, Yoshida, Hiroyuki, MD, PhD, Vergote, Ignace, MD, PhD, Colombo, Nicoletta, MD, Hietanen, Sakari, MD, Provansal, Magali, MD, Schmalfeldt, Barbara, Pignata, Sandro, MD, PhD, Martin-Lorente, Cristina, MD, Berton, Dominique, MD, Runnebaum, Ingo, MD, Ray-Coquard, Isabelle, Prof

Get full text

Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial by Pfisterer, Jacobus, Prof, Shannon, Catherine M, MBBS, Baumann, Klaus, MD, Rau, Joern, MSc, Harter, Philipp, MD, Joly, Florence, Prof, Sehouli, Jalid, Prof, Canzler, Ulrich, MD, Schmalfeldt, Barbara, Prof, Dean, Andrew P, MD, Hein, Alexander, MD, Zeimet, Alain G, Prof, Hanker, Lars C, MD, Petit, Thierry, Prof, Marmé, Frederik, Prof, El-Balat, Ahmed, MD, Glasspool, Rosalind, MD, de Gregorio, Nikolaus, MD, Mahner, Sven, Prof, Meniawy, Tarek M, MD, Park-Simon, Tjoung-Won, Prof, Mouret-Reynier, Marie-Ange, MD, Costan, Cristina, MD, Meier, Werner, Prof, Reinthaller, Alexander, Prof, Goh, Jeffrey C, MD, L'Haridon, Tifenn, MD, Baron Hay, Sally, MD, Kommoss, Stefan, Prof, du Bois, Andreas, Prof, Kurtz, Jean-Emmanuel, Prof

Get full text

Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial by Colombo, Nicoletta, Prof, Biagioli, Elena, MSc, Harano, Kenichi, MD, Galli, Francesca, MSc, Hudson, Emma, MD, Antill, Yoland, MD, Choi, Chel Hun, MD, Rabaglio, Manuela, MD, Marmé, Frederic, MD, Marth, Christian, MD, Parma, Gabriella, MD, Fariñas-Madrid, Lorena, MD, Nishio, Shin, MD, Allan, Karen, BSc, Lee, Yeh Chen, MD, Piovano, Elisa, MD, Pardo, Beatriz, MD, Nakagawa, Satoshi, MD, McQueen, John, MD, Zamagni, Claudio, MD, Manso, Luis, MD, Takehara, Kazuhiro, MD, Tasca, Giulia, MD, Ferrero, Annamaria, MD, Tognon, Germana, MD, Lissoni, Andrea Alberto, MD, Petrella, Mariacristina, MD, Laudani, Maria Elena, MD, Rulli, Eliana, PhD, Uggeri, Sara, MSc, Barretina Ginesta, M Pilar, MD

Get full text

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial by Vergote, Ignace, PhD, Scambia, Giovanni, MD, O'Malley, David M, MD, Van Calster, Ben, PhD, Park, Sang-Yoon, PhD, del Campo, Josep M, MD, Meier, Werner, PhD, Bamias, Aristotelis, PhD, Colombo, Nicoletta, MD, Wenham, Robert M, MD, Covens, Al, MD, Marth, Christian, PhD, Raza Mirza, Mansoor, MD, Kroep, Judith R, MD, Ma, Haijun, PhD, Pickett, Cheryl A, PhD, Monk, Bradley J, MD

Get full text

Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy by Bader, Arnim A, Prof, Schlembach, Dietmar, MD, Tamussino, Karl F, Prof, Pristauz, Gunda, MD, Petru, Edgar, Ptof

Get full text